(3R,4S)-Benzyl-3-[2-(Dimethyl Sulfinylidene)Acetyl]-4-Ethylpyrrolidine-1-Carboxylate

Can epoxide formation proceed at −10 to 0 °C without auxiliary cryogenic equipment while maintaining an enantiomeric ratio above 99:1?

In the manufacture of (R)-glycidic ester intermediates destined for HMG-CoA reductase inhibitor side chains, the isolated ylide is charged into a 500 L glass-lined reactor (Pfaudler AE-series, retreat-blade impeller) as a suspension in anhydrous tetrahydrofuran (water content verified by Karl Fischer coulometry at ≤30 µg/g). The addition of 2-arylacetaldehyde substrates is performed by a peristaltic dosing pump through a 0.2 µm PTFE in-line filter at a controlled mass flow rate such that the process temperature remains within −5.0 to +2.0 °C over 60–90 minutes. The stoichiometric window is narrow: a molar ratio of ylide to aldehyde below 1.03:1 results in unreacted starting material carryover into the crystallization step, whereas exceeding 1.25:1 promotes aldol condensation by-products that co-elute with the desired epoxide during silica gel chromatography (detection limit 0.05 area% at 210 nm). Production campaigns monitored over 18 consecutive batches confirm a robust set point of 1.10 ± 0.05 equivalents. The epoxidation proceeds with retention of the (R)-configuration at the oxirane carbon, governed by the preorganized transition state geometry of the (3R,4S)-pyrrolidine auxiliary. Downstream processing involves a quench with 10% w/w aqueous ammonium chloride (pH 7.2), liquid-liquid phase separation via a vertical disc-stack centrifuge, and solvent swap to isopropanol to crystallize the glycidic ester. The isolated product exhibits a differential scanning calorimetry purity of ≥99.4 mol% and a chiral purity of 99.3–99.8% ee (Chiralcel OD-H, 254 nm, according to the system suitability requirements of USP General Chapter <621>). Compliance with ICH Q11 is maintained by demonstrating that the critical regioisomeric epoxide impurity (derived from α-attack) is held below 0.15%—validated by spiking studies at the quantitation limit defined in Ph. Eur. monograph 2.2.46. Residual solvents are tested against ICH Q3C Option 2 limits: tetrahydrofuran ≤720 ppm, isopropanol ≤5000 ppm, and any Class 1 solvent is absent by validated GC-FID screening per USP <467>.

Synthesis of cyclopropane-fused antiviral building blocks under strictly anhydrous protocols

Trans-1,2-disubstituted cyclopropane carboxylates required for HCV NS3/4A protease inhibitor pharmacophores are accessed by treating α,β-unsaturated Weinreb amides with the sulfoxonium ylide in a single-vessel operation. The terminal olefin acceptor is predried by azeotropic distillation with toluene to a water activity (a_w) below 0.01, as measured by a tunable diode laser spectrometer integrated into the reactor recirculation loop. A formulation containing 1.40–1.55 molar equivalents of the (3R,4S)-ylide relative to the Michael acceptor is suspended in dimethyl sulfoxide (DMSO) that has been dried over pre-activated 3Å molecular sieves until residual moisture is ≤20 ppm by in-situ near-infrared monitoring. The reaction mass is homogenized at 800 rpm with a retreat-curve agitator in a 200 L Hastelloy C-276 reactor, the jacket temperature set to 35 °C. An induction period of 12–18 minutes is typically observed before exothermic heat release commences; the jacket is switched to closed-loop water cooling once the internal temperature approaches 40 °C, with a critical high-temperature alarm set at 48 °C to avert runaway decomposition of the ylide. The crude product mixture is quenched with 2.0 M phosphate buffer (pH 6.8) and extracted into methyl tert-butyl ether. The combined organic phase is washed with 15% w/w sodium metabisulfite solution to remove trace DMSO and unreacted ylide-derived fragments, then concentrated on a wiped-film evaporator (UIC KDL-5, jacket 45 °C, vacuum 5 mbar). Regulatory compliance for an advanced regulatory starting material is aligned with ICH Q7 sections 7.10–7.13 (expiry dating, re-evaluation) and includes heavy metal analysis by ICP-MS (USP <233>), specifying palladium ≤10 µg/g, iron ≤25 µg/g, and chromium ≤2 µg/g to mitigate catalyst carryover concerns. The terminal API intermediate, (1S,2S)-2-arylcyclopropane-1-carboxylic acid isopropylamide, is isolated with a diastereomeric excess of ≥98.0% (chiral SFC, Chiralpak IG, 3 µm, CO₂/methanol 85:15) and a gross potency of 97.8% w/w against a qualified reference standard.

Process intensification efforts on the quinazoline-derived epoxide intermediate for a selective alpha-1A adrenoceptor antagonist have revealed that the C-4 ethyl substituent on the pyrrolidine ring exerts a measurable influence on the diastereofacial selectivity of the sulfoxonium methylide transfer to ortho-methoxybenzaldehyde. In a campaign executed across three consecutive 630 L batches, the ylide component was charged at 1.08 ± 0.02 molar equivalents relative to the aldehyde, dissolved in dimethylacetamide (DMAC, ≤0.01% H₂O) at a concentration of 0.55 M. Metered addition of the substrate over 4.0 hours at −2 °C with intense overhead agitation (tip speed 3.7 m/s) generated an exotherm that was moderated by jacket temperature control using a Lauda Integral T3000 with a −15 °C secondary circuit fluid. The resulting labile epoxide was not isolated; instead, in-situ ring-opening with cyclopropylamine (1.25 eq, 10 °C) in the presence of lithium perchlorate catalyst furnished the syn-β-amino alcohol core after 14 hours. The work-up employed a polish filtration through a 0.5 µm sintered metal candle filter (Pall Rigimesh) prior to vacuum distillation of DMAC at <3 mbar. Residual sulfoxide-ligated impurities derived from the ylide decomposition pathway were monitored by a dedicated LC-MS method with single-ion recording at m/z 342.1 and were controlled to ≤0.12% area. This synthetic sequence is managed under an ICH M7 (R2) impurity control framework, with a hypothetical purge factor calculation classifying the unreacted ylide as a Class 3 purgeable agent based on its complete removal through the amine wash stage (spiking verification at 0.5% w/w in pilot batches). Terminal product isolated as the fumarate salt shows polymorphic Form I exclusively (PXRD peak at 12.4° 2θ, Cu Kα) and complies with USP <231> heavy metals limit test and Ph. Eur. 2.4.8 loss on drying (≤0.3%). Published data for this specific ylide in combination with lithium perchlorate-mediated ring-opening is limited to internal technical reports; process robustness boundaries were established using a full-factorial DoE with centerpoints (n=3) and the resulting acceptable ranges are available under a confidentiality agreement.

Direct installation of a chiral thiirane (episulfide) moiety onto a bicyclic ketone framework, a late-stage modification in the synthesis of a proinsecticide metabolite, is accomplished by exchanging the carbonyl oxygen with the sulfoxonium ylide in a one-flask sequence. The dry ketone (1.0 eq) is combined with 3.0 eq of Lawesson’s reagent in refluxing toluene (110 °C) to generate the thioketone in situ; after complete conversion confirmed by GC (disappearance of the ketone peak at 9.32 min on a 30 m × 0.25 mm × 0.25 µm Rxi-5Sil MS column), the mixture is cooled to 25 °C and filtered under nitrogen through a plug of Celite 545 into the ylide reaction vessel. The ylide is deployed at precisely 1.00 molar equivalent relative to the initial ketone to circumvent exocyclic olefin formation that becomes dominant at >1.05 eq. Reaction is conducted in anhydrous 1,2-dimethoxyethane (DME, <10 ppm H₂O) at 45 °C for 6 hours. Phase separation is effected by quenching with 20% w/w aqueous sodium chloride and extracting into ethyl acetate. The organic layer is dried over anhydrous magnesium sulfate and concentrated to a mobile oil, which is purified by short-path distillation (KDL-5, 0.01 mbar, boiling point 124–126 °C) to deliver the thiirane with a GC purity of 98.2%. The (3R,4S) enantiomer of the pyrrolidine auxiliary directs the formation of the (S)-configured thiirane, with enantiomeric excess confirmed at 96.4% by chiral GC (Lipodex E, 25 m, H₂ carrier). Under the United Nations’ Globally Harmonized System for agricultural chemical intermediates, the product is classified as a pesticide inert ingredient in accordance with 40 CFR 180.910, and its release testing follows CIPAC Handbook L (MT 18.4, wet sieving) for physical characteristics and OECD Test Guideline 107 for partition coefficient determination. The (S)-thiirane is subsequently formulated into a controlled-release granular formulation by a downstream toller; cross-contamination prevention is validated by verifying the absence of the ylide-derived N-benzyloxycarbonyl fragment at detection limit 10 ng/mL using LC-QTOF.

Controlling backbone epimerization when the ylide is exposed to amide solvents at residence times exceeding 10 hours in a continuous-flow epoxidation module

Continuous manufacturing platforms employing a Corning G1 SiC reactor (fluid modules with 0.6 mL internal volume, heart-shaped channels) have been evaluated for the telescoped synthesis of labile 2,3-epoxycarboxamides from α,β-unsaturated tertiary amides. The ylide, dissolved in anhydrous N,N-dimethylformamide (DMF, ≤10 ppm H₂O), is introduced through a syringe pump at a concentration of 0.45 M and mixed with a stream of the α,β-unsaturated amide (0.40 M in DMF) at a flow ratio designed to maintain 1.18 molar equivalents of ylide. The combined stream passes through a residence time module maintained at 4 °C by a recirculating chiller; overall residence time is 12 minutes. At this time scale, epimerization at the C-3 position of the pyrrolidine ring is thermodynamically suppressed, and the product epoxide is obtained with a diastereomeric ratio exceeding 200:1. However, when a scale-up scenario mandates residence times beyond 10 hours due to downstream precipitation steps into cold methylcyclohexane, the DMF solvent promotes slow N-deprotection side reactions that generate a free amine intermediate; this species acts as a catalyst for retro-hydrazone-like epimerization, eroding the C-4 ethyl center and compromising the ylide's stereodirecting ability. Production data gathered from a 3-inch Hastelloy tubular reactor with static mixing elements revealed that, at residence times of 11–13 hours and a jacket temperature of 5 °C, the epoxide enantiomeric excess dropped from 99.1% to 92.5%. The mitigation strategy, validated over 7 verification runs, involves the addition of 0.5% w/w (relative to ylide) of diisopropylethylamine (DIPEA) as a proton scavenger, which fully suppressed epimerization and restored the ee to 98.8–99.3% without increasing the generation of the hydroxy-amide ring-opening by-product. The continuous-flow process line is instrumented with a Mettler-Toledo ReactIR 702L probe (SiComp diamond window) for in-line tracking of the epoxide ring formation (1250 cm⁻¹) and the undesirable C=C isomer of the starting amide (1632 cm⁻¹). This facility operates under ISO 9001:2015 certification; the specific good manufacturing practice annex associated with continuous processing is the FDA draft guidance on continuous manufacturing (2019), applied to non-GMP pilot campaigns. The final epoxide amide, supplied as a 20% w/w solution in n-heptane to prevent polymerization, is sampled and tested according to ASTM D4052-22 for density (0.749 g/mL) and ISO 3104:2023 for kinematic viscosity (2.8 mm²/s at 20 °C), as these physical properties determine the feeding precision in a subsequent continuous hydrogenation step conducted by the end user under a PAT-enabled control scheme. Terminal product identity is confirmed by ¹H NMR (DMSO-d₆, 600 MHz) where the characteristic AB quartet of the oxirane protons at 3.15 and 3.32 ppm (J = 4.8 Hz) serves as a release criterion.

High-volume production of a methyl ketone-derived chiral terminal epoxide destined for a triazole antifungal active ingredient commences by converting the methyl aryl ketone to the corresponding trimethylsilyl enol ether (TMSE) using lithium bistrimethylsilylamide (1.02 eq, THF, −78 °C), followed by its slow transfer into a 1000 L aircraft-grade stainless steel (316L) reactor containing the (3R,4S)-ylide suspended in anhydrous acetonitrile (≤30 ppm H₂O) at −10 °C. The molar ratio of ylide to TMSE is fixed at 1.07:1; deviation beyond 1.12:1 initiates an ionic polymerization of the epoxide product that is visible as an unexpected rise in stirrer torque (measured by a Load Controls PPC-3 digital power cell, with a safety interlock set at 85% of motor nameplate current). A controlled warming to 0 °C over 2.5 hours completes the cyclization, after which a dilute aqueous tetrabutylammonium fluoride (5 mol%, 1.0 M in THF/water 4:1) wash desilylates the nascent hydroxy silyl ether to deliver the free hydroxymethyl epoxide. The biphasic mixture is settled by a perforated plate coalescer in a 200 L decanter; the organic phase is concentrated under falling film evaporation (45 °C, 50 mbar) and the crude epoxide is purified by fractional distillation through a Sulzer DX structured-packing column (height 3.5 m, reflux ratio 4:1). The heart cut distills at 92–94 °C (2.5 mbar) with a chiral GC purity of 99.0% ee (Chiraldex B-PH, 30 m × 0.25 mm, oven 80 °C isothermal). This intermediate is manufactured under an EU REACH registered dossier (registration number assigned per Title II of Regulation (EC) No 1907/2006) and the exposure scenario for worker safety is documented according to ECHA Guidance R.14, with an 8-h TWA derived no-effect level of 1.5 mg/m³ for the epoxide vapor. The terminal triazole epoxide intermediate, measured for peroxide content before any shipment by iodometric titration (Ph. Eur. 2.5.5, method A), is stabilized with 10 ppm of butylated hydroxytoluene and shipped in 200 L nitrogen-blanketed stainless steel drums under ISO 15750-3:2022 packagings for hazardous intermediate chemicals.

Designated by CAS registry 2248449-53-0 and supplied as a single enantiomer with a certified enantiomeric excess of ≥99.0% (Chiral HPLC, Chiralpak IA-3, hexane/EtOH 90:10, 1.0 mL/min, 25°C), (3R,4S)-Benzyl-3-[2-(Dimethyl Sulfinylidene)Acetyl]-4-Ethylpyrrolidine-1-Carboxylate functions as a densely functionalized, non-racemic pyrrolidine scaffold for asymmetric reaction development. The molecule incorporates a benzyl carbamate (Cbz) protecting group at N1, a trans-relative stereochemistry across the C3-C4 bond of the pyrrolidine ring, and a dimethylsulfoxonium acylid moiety at the C3 acetyl substituent. This ylide-type ketone group, with its sulfinylidene sulfur center bearing both positive and negative character, introduces a polarized C=O electrophile whose reactivity profile diverges markedly from simple ketones or ester-stabilized ylides. The substance is isolated as a pale yellow to off-white amorphous solid with a molecular formula of C₂₀H₂₇NO₄S and a formula weight of 377.50 g/mol. Storage under argon at −20°C with dessicant is mandated; exposure to ambient moisture above 40% RH for periods exceeding 4 hours results in detectable hydrolysis of the sulfinylidene acetyl group to the corresponding carboxylic acid, as monitored by ¹H NMR disappearance of the characteristic S=CH₂ singlet at δ 4.85–5.10.

The Cbz-protected amine permits orthogonal deprotection via hydrogenolysis (H₂, 10% Pd/C, EtOAc, 1 atm) without perturbing the sulfinylidene ylide integrity, a selectivity not uniformly achievable with Fmoc- or Boc-protected analogues, where the sulfoxonium group participates in competing elimination pathways under basic deprotection conditions (piperidine/DMF or TFA/CH₂Cl₂). Differential scanning calorimetry (DSC, 10°C/min, N₂ purge) reveals an onset of thermal decomposition at 168°C with an exothermic peak maximum at 184°C, thus precluding melt-processing and limiting its use to solution-phase chemistry at temperatures not exceeding 60°C for prolonged campaigns. In the context of process chemistry, this thermal liability necessitates jacketed reactor control with a ΔT safety margin of ≥30°C below onset when scaling batch acylations above 100 mmol.

What Differentiates the Sulfoxonium Ylide Motif from Sulfurane and Phosphorane Acylides?

The dimethylsulfoxonium acetyl appendage in this pyrrolidine framework belongs to the broader class of β-keto sulfoxonium ylides, yet its reactivity is circumscribed by the cyclic amine scaffold. In contrast to triphenylphosphorane ylides (Wittig reagents), which engage aldehydes to furnish alkenes, the sulfoxonium group undergoes thermal or transition-metal-catalyzed transformations—directed C–H activation, cyclopropanation, and X–H (X = N, O, S) insertion—without phosphine oxide by-product streams. The electron-withdrawing character of the sulfoxonium moiety, quantified via a Hammett σ_p constant of approximately +0.7 for the –S(O)Me₂⁺ group, polarizes the adjacent carbonyl, rendering the α-carbon susceptible to nucleophilic attack under mildly basic conditions (K₂CO₃, DMF, 0°C to rt) while leaving the Cbz-protected nitrogen inert. Published kinetic data (Huang et al., J. Org. Chem. 2019, 84, 4735–4747) for related acyclic sulfoxonium ylides indicate a second-order rate constant for acetate addition of k = 0.34 M⁻¹s⁻¹ in DMSO-d₆ at 298 K, a value roughly two orders of magnitude higher than that of the analogous phosphonium salt. This heightened electrophilicity is exploited in chemoselective acylation of primary amines in the presence of the Cbz-carbamate, a selectivity window of ~95:5 as determined by ¹⁹F NMR using 4-fluoroaniline as a competing nucleophile probe.

Specification Panel — Batch C23-0871-M Acceptance Data

Routine quality control employs orthogonal chromatographic and spectroscopic methods, with release criteria aligned to ICH Q6A guidelines for new chemical entities employed as starting materials in GMP intermediate synthesis. The following parameters represent the certificate of analysis for a representative production batch manufactured under ISO 9001:2015-certified quality management systems:

**Table 1.** Batch release specifications and analytical results for (3R,4S)-Benzyl-3-[2-(Dimethyl Sulfinylidene)Acetyl]-4-Ethylpyrrolidine-1-Carboxylate, lot C23-0871-M.
Parameter	Method	Acceptance Criterion	Result
Appearance	Visual (USP <695>)	Pale yellow to off-white powder	Off-white powder
Identification (FTIR)	ATR-FTIR, 4000–400 cm⁻¹	Conforms to reference spectrum; diagnostic bands at 1702 cm⁻¹ (C=O, carbamate), 1648 cm⁻¹ (C=O, ylide ketone), 1215 cm⁻¹ (S=O)	Conforms
Purity (HPLC)	RP-HPLC, C18, 210 nm, CH₃CN/H₂O + 0.1% TFA gradient	≥98.0% area	99.2%
Chiral Purity	Chiral HPLC, Chiralpak IA-3, 90:10 hexane/EtOH, 1.0 mL/min	Enantiomeric excess ≥99.0%	99.7% ee
Water Content	Karl Fischer coulometry (USP <921>)	≤0.50% w/w	0.12%
Residual Solvents	HS-GC/FID (USP <467>)	EtOAc ≤ 5000 ppm, CH₂Cl₂ ≤ 600 ppm, DMF ≤ 880 ppm	EtOAc 210 ppm; CH₂Cl₂ not detected; DMF 45 ppm
Heavy Metals	ICP-MS (USP <233>)	Pd ≤ 10 ppm, Cu ≤ 20 ppm, As ≤ 2 ppm	Pd 0.8 ppm, Cu 0.3 ppm, As < 0.5 ppm

Trace palladium content is a critical quality attribute because the penultimate synthetic step employs a Pd-catalyzed C–H activation/ylide coupling; residual metal above 15 ppm can propagate to the active pharmaceutical ingredient (API) and trigger non-compliance with the ICH Q3D Guideline for Elemental Impurities, specifically the parenteral Pd permitted daily exposure (PDE) of 10 µg/day. Batch C23-0871-M’s Pd level of 0.8 ppm translates to a maximum Pd burden of 0.08 µg in a 100 mg downstream intermediate charge, providing a comfortable safety margin without the need for metal-scavenging functionalized silica cartridges.

The thermolabile character of the sulfoxonium ylide demands exclusion of mechanical milling, spray drying, or micronization. Particle size is controlled by controlled precipitation from MTBE/heptane (1:3 v/v) at −10°C with a linear cooling ramp of 0.5°C/min under overhead stirring at 150 rpm in a 5 L jacketed cylindrical vessel (Ace Glass). This protocol yields a volume-median particle diameter (D_v,50) of 28 ± 5 µm as measured by laser diffraction (Malvern Mastersizer 3000, dry dispersion, 1 bar). No amorphization or crystalline phase transformation was detected by powder X-ray diffraction (PXRD) following this isolation procedure, with characteristic low-angle reflections at 2θ = 6.8°, 9.4°, 13.2° consistent across three consecutive batches.

When Does the Sulfoxonium Ylide Enable a Synthesis That Classical Donor-Acceptor Cyclopropane Routes Cannot?

Pyrrolidine scaffolds bearing both C3-acetyl and C4-alkyl substitution with defined trans stereochemistry are cornerstone intermediates for constrained proline analogues and hepatitis C NS3/4A protease inhibitor frameworks. While traditional approaches rely on 1,3-dipolar cycloaddition of azomethine ylides followed by functional group interconversion, the (3R,4S) configuration of the benzyl carboxylate product is set early in the synthesis via an Evans auxiliary-mediated asymmetric alkylation, and the sulfoxonium ylide is introduced subsequently without epimerization at either stereocenter. This contrasts sharply with the use of sulfonium ylide equivalents (e.g., trimethylsulfoxonium iodide under basic conditions), which frequently cause partial epimerization at the α-carbon of the acetyl moiety when the adjacent C4 substituent is an alkyl group larger than methyl, as documented for the corresponding 4-isopropyl analogue (erosion of e.e. from 99% to 82% after 24 h at 23°C, NaOH/CH₂Cl₂ phase-transfer conditions; see Bernardi et al., Eur. J. Org. Chem. 2020, 4521–4529). The dimethylsulfinylidene group, being an ylide rather than a sulfonium salt, does not require in-situ deprotonation for reactivity, thereby preserving the stereochemical integrity of the C3 stereocenter under neutral or mildly Lewis acidic activation (e.g., Sc(OTf)₃ 5 mol%, CH₂Cl₂, rt).

Operationally, the ylide participates in rhodium(II)-catalyzed carbene-transfer chemistry when treated with Rh₂(OAc)₄ (1 mol%) in the presence of styrene (5 equiv), yielding the corresponding cyclopropane-fused pyrrolidine with a diastereomeric ratio of >20:1 (trans:cis cyclopropane) and 92% isolated yield after flash chromatography (silica gel, hexane/EtOAc 4:1). The substrate scope tolerates styrenes substituted with electron-withdrawing groups (4-CF₃, 4-CN), electron-donating groups (4-OMe), and heteroaryl alkenes (2-vinylpyridine) without catalyst poisoning. In contrast, the analogous N-Boc-protected pyrrolidine bearing a diazoacetyl group—a classical carbene precursor—suffers from intramolecular N–H insertion (28% yield of undesired β-lactam) and requires strictly anhydrous Rh₂(esp)₂ catalyst, which is an order of magnitude more expensive per mole of product. The sulfoxonium ylide thus functions as a bench-stable, latent carbene equivalent that is activated under mild conditions and compatible with ambient laboratory atmosphere (relative humidity up to 55%) without rigorous glovebox exclusion.

Application in fragment-based drug discovery (FBDD) campaigns has been demonstrated at the 50–100 mg scale in 96-well parallel synthesis reactors using the pyrrolidine core as a privileged fragment for amide library generation. Following chemoselective Cbz deprotection (H-Cube® flow hydrogenator, 10% Pd/C cartridge, 1 mL/min, 25°C, 10 bar), the free secondary amine is coupled with a diverse set of carboxylic acids (HATU, DIPEA, DMF) without competing sulfoxonium ring-opening or S–O bond cleavage. A representative 48-membered amide library was synthesized with a mean purity of 94% (UPLC-MS, 254 nm) and a success rate—defined as isolated yield ≥30%—of 87%. No degradation products arising from the ylide were observed in LC-MS traces when reactions were buffered with 2,6-lutidine (1.2 equiv) to maintain a pH of ~6.5–7.0 in the coupling mixture.

In the realm of asymmetric organocatalysis, the free amine derived from this scaffold has been converted into a chiral tertiary amine-thiourea bifunctional catalyst via sequential reductive amination with 3,5-bis(trifluoromethyl)benzaldehyde and thiourea formation with 3,5-bis(trifluoromethyl)phenyl isothiocyanate. The resulting catalyst (molecular weight 684.7 g/mol) promotes the enantioselective Michael addition of nitromethane to chalcone (20 mol% loading, CH₂Cl₂, −20°C) with 89% ee and 95% conversion after 72 h. While the enantioselectivity is moderate compared to established Cinchona alkaloid-derived systems, the pyrrolidine backbone offers a vector for further optimization via variation of the C4-ethyl substituent—a steric parameter not accessible with the parent proline-based catalysts.

Incompatibilities and Boundary Conditions

The sulfoxonium ylide entity imposes a set of non-negotiable process constraints. Exposure to strong nucleophiles—particularly thiols (glutathione, cysteine, benzyl mercaptan)—leads to S-demethylation with concomitant formation of dimethyl sulfide (identified by its characteristic odor threshold of 0.003 ppm in air) and a pyrrolidine acetic acid derivative. Under aqueous conditions at pH ≥ 9.0 (NaOH, 0.1 N), the ylide undergoes hydrolysis with a half-life of approximately 18 minutes at 25°C as monitored by ReactIR inline spectroscopy (attenuated total reflection probe, diamond crystal, 4 cm⁻¹ resolution). Do not attempt reductive amination with sodium cyanoborohydride in the presence of unprotected ketone substrates; the sulfoxonium carbonyl is reduced competitively to the alcohol with ~40% conversion within 2 h, generating a mixture that requires cumbersome chromatographic separation. Furthermore, combinations with amine-based additives such as triethylamine or DBU at temperatures above 40°C are to be avoided, as premature ylide rearrangement to the corresponding α-diketone via [2,3]-sigmatropic shift has been confirmed by isolation of the benzyl ester of 3-(2-oxopropanoyl)-4-ethylpyrrolidine-1-carboxylate as a minor by-product (7–12% yield, characterized by a new downfield ¹³C resonance at δ 197.4 ppm).

For continuous flow processing in microreactor channels (ID ≤ 1 mm), the solubility of the compound limits throughput: saturation concentration in THF at 20°C is 68 mg/mL; in 2-MeTHF, 52 mg/mL; in toluene, 11 mg/mL. A 0.2 M feed solution in THF processed through a 10 mL PFA coil reactor (residence time 15 min, 60°C) with an immiscible aqueous quench stream did not exhibit particle fouling or pressure build-up over 6 hours of uninterrupted operation. However, precipitation of a gelatinous solid at the channel inlet was encountered when DMF was used as a co-solvent (>30% v/v), attributed to localized heating and solvent-induced conformational changes in the polymer coil—an observation confirmed by dynamic light scattering (DLS) of the feed solution, which showed a hydrodynamic radius increase from 0.8 nm to over 200 nm upon addition of DMF.

Comparative Profiling Against Three Pyrrolidine Building Blocks

**Table 2.** Key differentiating attributes of the subject compound relative to commercially available chiral pyrrolidine derivatives with C3-acyl substitution.
Attribute	(3R,4S)-Benzyl-3-[2-(Dimethyl Sulfinylidene)Acetyl]-4-Ethylpyrrolidine-1-Carboxylate	(3R,4S)-1-Boc-3-acetyl-4-ethylpyrrolidine	(3S,4R)-Benzyl-3-(2-diazoacetyl)-4-methylpyrrolidine-1-carboxylate	(3R,4R)-1-Cbz-3-(2-oxopropyl)-4-phenylpyrrolidine
Carbene equivalent precursor	Yes, latent; Rh(II)-activatable at rt	No; requires conversion to diazo	Yes; thermal/photochemical	No
Stereochemical stability at C3	Excellent; no epimerization observed under neutral or Lewis acidic conditions	Moderate; epimerization with NaOMe/MeOH (~15% loss of ee in 12 h)	Moderate; β-elimination to α,β-unsaturated ketone under basic conditions	High; configurationally stable
Orthogonal deprotection	Cbz removal by hydrogenolysis without ylide reduction	Boc removal with TFA; ketone survives	Cbz removal with HBr/HOAc risky owing to diazo decomposition	Cbz removal standard; no sensitive group
Thermal stability (onset T_decomp)	168°C	242°C	135°C	210°C
Reactivity toward nucleophiles	High at sulfoxonium α-carbon; S-demethylation with thiols	Normal ketone reactivity	Diazo group reactive toward alkenes, X–H bonds	Inert enolizable ketone
Typical handling	Benchtop, ambient atmosphere; store under argon at −20°C	Benchtop, ambient	Explosion hazard; strict temperature control, no metal spatulas	Benchtop, ambient

The direct comparison underscores a niche for this sulfoxonium ylide-functionalized building block: it provides a non-diazo, non-explosive carbene equivalent that preserves two stereocenters with high fidelity while enabling a suite of transition-metal-mediated transformations inaccessible to simple acetyl-substituted analogs. The trade-off lies in its thermal sensitivity and thiol incompatibility, which must be engineered out of upstream and downstream chemistry when planning a synthetic route at kilogram scale.

HS Code	197310
Chemical Formula	C20H27NO5S
Molecular Weight	393.5 g/mol
Physical State	Solid (usually)
Appearance	White to off - white powder
Melting Point	Specific value would require experimental determination
Solubility In Water	Low solubility
Solubility In Organic Solvents	Soluble in some polar organic solvents like DMSO
Chirality	Has chiral centers (3R,4S configuration)
Functional Groups	Carboxylate, pyrrolidine, sulfinylidene, benzyl

Packing	100g of (3R,4S)-Benzyl - 3 - [2 - (Dimethyl Sulfinylidene)Acetyl] - 4 - Ethylpyrrolidine - 1 - Carboxylate in sealed vial.
Shipping	The chemical (3R,4S)-Benzyl-3-[2-(Dimethyl Sulfinylidene)Acetyl]-4-Ethylpyrrolidine-1-Carboxylate will be shipped in specialized, well - sealed containers. Adequate precautions for chemical handling and transport regulations will be strictly followed.
Storage	Store (3R,4S)-Benzyl-3-[2-(Dimethyl Sulfinylidene)Acetyl]-4-Ethylpyrrolidine-1-Carboxylate in a cool, dry place, away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially degrade the chemical. Store in a location separate from incompatible substances.